Filter
News & Insights
- Private Capital
From grand slam to grand venture: An interview with Serena Williams
Read More - Private Capital
The future of the world of credit: Perspectives from SuperReturn International 2025
Read More - Compliance & Legal, Biotech & Pharma
Challenges and AI solutions for HCP engagement expense auditing
Read More - IGM
North American FX Open - HK pensions warning on USTs pre-CPI
Read More - IGM
CORP SNAPSHOT: Issuers flood out the pipeline
Read More - IGM
DAILY CLOSE: Variety on offer in primary, US-China talks look positive
Read More - IGM
European FX Open - The UK spending review & US CPI
Read More - IGM
Asian FX Close: Dollar Drifts Sideways as Gold Holds $3,300 While Yen Weakens to 145
Read More - IGM
CREDIT OPEN: US-China trade talks result in framework adoption
Read More - IGM
CEEMEA OPEN: Focus turns from US-China trade talks to US CPI
Read More - IGM
[MORNING CALL] Proceed With Caution
Read More - Clinical & Medical AffairsClinical Insider
Quantum Biopharma opts for Australia for Phase II MCAS/D pain drug trial
Read More - Compliance & Legal, Biotech & Pharma
Pharma’s expanding field roles challenge traditional boundaries
Read More - Clinical & Medical AffairsClinical Insider
EMA issues guide on including pregnant and breastfeeding people in trials
Read More - Clinical & Medical AffairsClinical Insider
Competition in IRT/RTSM market driving development of innovative tech
Read More - Zephyr
Building a Self-Sustaining Financial Advisory Practice with Jason Smith
Read More - Compliance & Legal, Biotech & Pharma
Top high-risk areas in pharmaceutical M&A transactions
Read More - IGM
CREDIT BULLETS: Pipeline grows, trade talks in focus
Read More - IGM
CEEMEA OPEN: Eyes fixed on US-China trade talks
Read More - IGM
CORP SNAPSHOT: Mandates announced on Whit Monday
Read More